National Cancer Institute's Affordable Cancer Technologies (ACTs) Program
Abstract
The National Cancer Institute's Affordable Cancer Technologies (ACTs) Program marks a decade of success in supporting translational research. This initiative focuses on delivering affordable, scalable cancer prevention and control solutions for low- and middle-income countries. The program has funded 38 grants resulting in patents, publications, and the adoption of novel approaches, including point-of-care diagnostics for colorectal cancer and HPV, and new technologies for chemotherapy surveillance and cervical precancer treatment. ACTs accelerate life-saving innovations from the lab to real-world communities.
Fields of Study & Subjects
Biotechnology and Related Fields
Global Cancer Incidence and Screening
Advances in Oncology and Radiotherapy
Publication details
- Journal / source
- JCO Global Oncology
- Publisher
- American Society of Clinical Oncology (ASCO)
- Volume
- 12
- Issue
- 1
- Pages
- e2500689–e2500689
- Publication date
- 1 January 2026
- Language
- EN